Do you have cancer that has a PIK3CA Mutation?

Discover a clinical trial opportunity with the ReDiscover study- evaluating a new potential way to help people with PIK3CA mutations.

Study participation may help offer insight into the safety and activity of a mutant selective PI3KCA inhibitor in patients with PI3KCA mutant tumors.

Learn More
About the Study
Study Drug
PIK3CA Mutation
About Clinical Research
Study Clinic Locations

Contact a study centre near you

The ReDiscover study will offer travel reimbursement to a study centre for participants and caregivers. Find a location near you  and contact them to learn about your eligibility.

Study Centre Locations
Study Information
HomeReDiscover StudyStudy DrugPIK3CA Mutation
Join the Study
Study Centre Locations
Resources
About Clinical ResearchClinicalTrials.gov
Privacy PolicyTerms and Conditions
This website is intended for Australia audiences only.
Stock photo(s) posed by model(s)
Copyright © 2025 Medpace